Tag: INDIAN PHARMA NEWS
JP Nadda Urges Bengal MPs to Join the Fight Against TB
Union Health Minister J.P. Naddamet with West Bengal's Members of Parliament in New Delhi on Wednesday, urging cross-party lawmakers to spearhead grassroots efforts against tuberculosis...
AstraZeneca reports Mixed Phase III Results for Ultomiris in Rare Post-Transplant Blood Disorder
AstraZeneca's Alexion unit has reported divergent outcomes from its late-stage program testing Ultomiris (ravulizumab) in patients with thrombotic microangiopathy following hematopoietic stem cell transplant (HSCT-TMA), a rare and...
Cipla Receives U.S. FDA Approval for Generic Advair Diskus®️
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., have received approval from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Application...
Government of Andhra Pradesh Partners to Launch AI and Genomic-Powered 360-Degree Oncology Care Model
The Government of Andhra Pradesh has announced a strategic partnership to implement a groundbreaking 360-degree oncology care model designed to transform early cancer detection,...
Cognizant Expands Strategic Partnership with Novartis to Transform Global IT Operations using Agentic AI
Cognizant has announced a new five-year, AI-enabled integrated IT operations agreement with Novartis, expanding a strategic relationship that spans more than two decades.
Under the...
Seven Clinical Trial Ethics Panels Lose CDSCO Registration in Compliance Crackdown
The Central Drugs Standard Control Organisation (CDSCO) has withdrawn registration certificates from seven Ethics Committees nationwide after risk-based audits uncovered serious lapses under the...
